0 39

Cited 0 times in

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer - Authors' reply

Authors
 Choong-Kun Lee  ;  Hye Jin Choi 
Citation
 LANCET GASTROENTEROLOGY & HEPATOLOGY, Vol.8(3) : 211-212, 2023-03 
Journal Title
LANCET GASTROENTEROLOGY & HEPATOLOGY
Issue Date
2023-03
MeSH
Antineoplastic Agents, Immunological* / therapeutic use ; Biliary Tract Neoplasms* / drug therapy ; Humans ; Receptor, ErbB-2 ; Trastuzumab / therapeutic use
Full Text
https://www.sciencedirect.com/science/article/pii/S2468125323000067
DOI
10.1016/S2468-1253(23)00006-7
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Choong-kun(이충근) ORCID logo https://orcid.org/0000-0001-5151-5096
Choi, Hye Jin(최혜진) ORCID logo https://orcid.org/0000-0001-5917-1400
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/198512
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links